Vitara V Research Overview
Vitara V 20mg Pharmaceutical is a branded tadalafil citrate formulation designed specifically for laboratory research applications. This pharmaceutical-grade compound represents a standardised preparation for investigating PDE5 inhibitory mechanisms in controlled research environments. Researchers at Stroid UK Shop study this compound’s molecular interactions within cellular signalling pathways. The 20mg dosage provides consistent research parameters for comparative studies examining phosphodiesterase enzyme inhibition and cyclic nucleotide regulation.
Research Applications
Laboratory studies evaluate Vitara V’s molecular mechanisms in vascular smooth muscle cell preparations and endothelial function models. Research protocols examine its selectivity for PDE5 enzyme systems compared to other phosphodiesterase isoforms. Cardiovascular research laboratories investigate this compound’s effects on nitric oxide-cGMP signalling pathways in tissue culture systems. Academic institutions studying tadalafil mechanisms utilise this preparation for enzyme kinetics analyses and receptor binding studies. Comparative pharmaceutical research examines bioavailability profiles and metabolic pathways using standardised assay systems. Research groups investigating vascular biology analyse this compound alongside other PDE inhibitors available in our SARM collections and peptide research materials for comprehensive pathway analysis.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Tadalafil Citrate |
| Strength | 20mg per unit |
| Form | Pharmaceutical tablets |
| Manufacturer | Vitara Pharmaceuticals |
| CAS Number | 171596-29-5 (Tadalafil) |
| Storage | Room temperature, dry conditions |
Laboratory Compliance
This product is manufactured exclusively for in-vitro research applications and laboratory studies. Vitara V 20mg is not intended for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory protocols and safety procedures when handling this material. All studies should comply with institutional research guidelines and appropriate regulatory frameworks for pharmaceutical research compounds.
